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ABSTRACT
Introduction: Cognitive decline related to neurocysticercosis (NC) remains poorly characterized and underdiagnosed. We have previously 
shown that a significant proportion of active NC patients (A-NC) present cognitive and functional impairment. Until now, there is no control 
study that have evaluated cognitive abnormalities in patients in the calcified phase of NC. Objective: To evaluate the cognitive performance of 
the largest subgroup of NC, the strict calcified patients (C-NC). Check the presence of dementia and cognitive impairment no dementia (CIND) 
and correlate the results with neuroimaging findings. Moreover, to investigate whether there is a spectrum of cognitive abnormalities in the 
disease according to disease phase. Method and participants: Forty treatment-naive patients with C-NC aged 37.6±11.3 years and fulfilling 
absolute criteria for definitive C-NC were submitted to a comprehensive cognitive and functional evaluation and were compared with 40 active 
NC patients (A-NC) and 40 healthy controls (HC) matched for age and education. All patients of C-NC group underwent brain MRI study in order 
to exclude other causes of epilepsy and signs of inflammatory activity. Results: Patients with C-NC presented 9.4±3.1 altered test scores out of 
the 30 from the cognitive battery when compared to HC. No C-NC patient had dementia and 10 patients (25%) presented CIND. The A-NC group 
had five patients (12.5%) with dementia and 11 patients (27.5%) with CIND. More than 50% of C-NC patients had low performance in verbal 
memory, attention and executive functions in comparison to CS. No significant correlation was found between cognitive performance and the 
number of lesions and seizure frequency. On follow-up, three out of five previously demented A-NC patients still presented cystic lesions with 
scolex on MRI and were still demented. One patient died and the remaining patient no longer fulfilled criteria for neither dementia nor CIND, 
presenting exclusively calcified lesions on neuroimaging. Conclusion: The results of our controlled study shows that NC, independently of its 
phase, leads to a spectrum of cognitive abnormalities, ranging from impairment in a single domain, to CIND and, occasionally, to dementia. 
These findings are more conspicuous during active vesicular phase and less prominent in calcified stages.
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